Catalyst Funds Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SW
Catalyst Funds Management's ASTH Position: Q4 2024 in Review
Catalyst Funds Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 900 shares — an estimated $52.1K sold.
Catalyst Funds Management first reported a position in ASTH in Q2 2024 and held it in 2 quarters. The position peaked at $52.1K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.
- Catalyst Funds Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
- Catalyst Funds Management sold 900 Astrana Health shares in Q4 2024, an estimated $52.1K.
- Catalyst Funds Management first reported a position in Astrana Health in Q2 2024 and held it in 2 quarters.
- Catalyst Funds Management's Astrana Health position peaked at $52.1K in Q3 2024.
- 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.
Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.